In a companion case to ALM Holding v. Zydex, the Federal Circuit held that Medtronic Ireland retained Article III standing to assert patent infringement counterclaims despite licensing exclusive rights to an affiliate, because it kept the right to sue, sublicensing veto, and royalty interests.
In a closely watched case, Judge Gilstrap denied a permanent injunction against Samsung despite a $445.5 million willful infringement verdict, finding that the non-practicing patent owner failed to show the balance of hardships favored relief — even though the court accepted its irreparable harm arg
In a patent litigation over cancer diagnostics, a federal court adopted sanctions totaling nearly $3 million against Quinn Emanuel and five named attorneys, plus a $100,000 punitive sanction and mandatory ethics training, for deliberately misleading the court about an expert’s access to embarg
In a precedential opinion, the Federal Circuit reversed a Delaware district court’s dismissal for lack of standing, holding that patent owners who retain the right to sue for infringement, a sublicensing veto, and royalty interests maintain Article III standing even after granting a broad excl
The full Federal Circuit denied en banc rehearing of its February 2026 panel decision affirming a $71.4 million verdict for infringement of Willis Electric’s pre-lit Christmas tree connector patent, rejecting Polygroup’s challenge to the damages expert methodology.
The Delhi High Court Division Bench reversed a single judge’s infringement and damages decree against DVD importers, holding that Philips failed to prove its DVD decoding patent was essential to the standard and that the defendants’ imports from licensed manufacturers triggered patent exhaustion und
The Supreme Court denied certiorari in CAO Lighting’s challenge arguing that the Federal Circuit’s one-line Rule 36 affirmances of PTAB decisions violate the statutory mandate for judicial ‘opinions’ under Loper Bright principles.
The Federal Circuit affirmed dismissal of a patent infringement case involving a unified electronic banking system, finding surviving claims obvious in light of an IPR outcome, but reversed both the exceptional-case attorney fee award and sanctions against counsel, holding that mere invalidity is in
A Delaware federal judge upheld two patents covering UCB’s Nayzilam seizure medication after a bench trial, finding that Cipla failed to prove the patents invalid as anticipated or obvious—preserving UCB’s market exclusivity just as the drug’s orphan drug protection expired.
A federal judge in San Francisco granted GoPro judgment as a matter of law that the sole remaining valid patent claim covering its action camera live-preview technology was invalid, overturning an $8.2 million jury damages award in a case that has been litigated for over a decade.